Alessandro Maria Vannucchi Selected Research

COVID-19

8/2023	Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature.
8/2021	JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy.
1/2021	Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.
1/2021	High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.
12/2020	Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Maria Vannucchi Research Topics

Disease

18	Neoplasms (Cancer) 01/2024 - 04/2015
18	Primary Myelofibrosis (Myelosclerosis) 01/2024 - 08/2002
9	Polycythemia Vera 06/2023 - 07/2011
7	Essential Thrombocythemia 01/2024 - 07/2011
5	Thrombosis (Thrombus) 01/2024 - 01/2017
5	COVID-19 08/2023 - 12/2020
4	Anemia 05/2020 - 08/2002
3	Thrombocytosis (Thrombocythemia) 01/2024 - 04/2015
3	Splenomegaly 01/2023 - 05/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 04/2021
2	Fibrosis (Cirrhosis) 01/2023 - 01/2023
2	Infections 01/2023 - 04/2015
2	Pneumonia (Pneumonitis) 08/2021 - 01/2021
1	Disease Progression 01/2024
1	Dizziness (Lightheadedness) 01/2024
1	Headache (Headaches) 01/2024
1	Paresthesia (Dysesthesia) 01/2024
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2023
1	Lymphoma (Lymphomas) 03/2023
1	Hodgkin Disease (Hodgkin's Disease) 03/2023
1	Leukemia 12/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022
1	Leukocytosis (Pleocytosis) 04/2022
1	Inflammation (Inflammations) 01/2022
1	Genomic Instability 01/2022
1	Pulmonary Arterial Hypertension 01/2022
1	Eosinophilia 11/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 06/2020
1	Hypoxia (Hypoxemia) 06/2020
1	Cytopenia 05/2020
1	Sarcoma (Soft Tissue Sarcoma) 05/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Hemorrhage 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 05/2016
1	Circulating Neoplastic Cells 05/2016
1	Breast Neoplasms (Breast Cancer) 05/2016

Drug/Important Bio-Agent (IBA)

8	ruxolitinibIBA 11/2022 - 03/2014
5	Janus Kinase InhibitorsIBA 12/2022 - 07/2017
5	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2020 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 03/2023 - 09/2021
3	CalreticulinIBA 01/2024 - 10/2020
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2023 - 11/2018
2	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 01/2022
2	C-Reactive ProteinIBA 01/2017 - 04/2015
1	Janus Kinase 2IBA 01/2024
1	Investigational DrugsIBA 01/2024
1	molnupiravirIBA 08/2023
1	nirmatrelvir and ritonavir drug combinationIBA 08/2023
1	VaccinesIBA 08/2023
1	Antiviral Agents (Antivirals)IBA 08/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2023
1	CytokinesIBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	reparixinIBA 01/2023
1	romiplostim FDA Link 01/2023
1	OsteopontinIBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	InterferonsIBA 12/2022
1	Proteins (Proteins, Gene)FDA Link 11/2022
1	navtemadlin; 2- ((3R,5R,6S)- 5- (3- chlorophenyl)- 6- (4- chlorophenyl)- 1- ((S)- 1- (isopropylsulfonyl)- 3- methylbutan- 2- yl)- 3- methyl- 2- oxopiperidin- 3- yl)acetic acidIBA 11/2022
1	ThromboxanesIBA 01/2022
1	venetoclaxIBA 04/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	RNA Splicing FactorsIBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 12/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2020
1	3- (2- ethylphenoxy)- 1- (1,2,3,4- tetrahydronaphth- 1- ylamino)- 2- propanol oxalateIBA 06/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020
1	Vitamin K FDA Link 01/2020
1	sonidegibIBA 01/2020
1	Drug CombinationsIBA 01/2019
1	Pipobroman (Vercyte)FDA Link 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 05/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2016
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 05/2016
1	Histone Deacetylase 1IBA 05/2016
1	Histone Deacetylase InhibitorsIBA 05/2016
1	Calcibiotic Root Canal SealerIBA 05/2016
1	diazonaphthalenedisulfonic acid (NDS)IBA 07/2011
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 07/2011
1	Messenger RNA (mRNA)IBA 07/2011
1	Protein Isoforms (Isoforms)IBA 07/2011
1	Hemoglobins (Hemoglobin)IBA 03/2010
1	A-Form DNA (A-DNA)IBA 09/2005

Therapy/Procedure

13	Therapeutics 01/2024 - 05/2016
2	Transplantation 01/2023 - 12/2022
1	Perioperative Care 01/2024
1	Cell Transplantation 01/2023
1	Contraindications 01/2023
1	Stem Cell Transplantation 12/2022
1	Drug Therapy (Chemotherapy) 04/2022
1	Operative Surgical Procedures 05/2020
1	Splenectomy 05/2020
1	Precision Medicine 05/2016